Pfizer Inc. buy Guggenheim
Start price
11.12.24
/
50%
€24.08
Target price
11.12.25
€31.40
Performance (%)
-8.29%
End price
12.12.25
€22.08
Summary
This prediction ended on 12.12.25 with a price of €22.08. With a performance of -8.29%, the BUY prediction by Guggenheim finished with a loss. Guggenheim has a follow-up prediction for Pfizer Inc. where he still thinks Pfizer Inc. is a Buy. Dividends of €0.41 are taken into consideration when calculating the performance. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Pfizer Inc. | -4.601% | -4.601% | -15.128% |
| iShares Core DAX® | 0.374% | 4.635% | 21.570% |
| iShares Nasdaq 100 | 1.487% | 2.950% | 6.389% |
| iShares Nikkei 225® | -0.725% | 0.403% | 14.348% |
| iShares S&P 500 | 0.822% | 2.058% | 3.773% |
Comments by Guggenheim for this prediction
In the thread Pfizer Inc. diskutieren
Pfizer Inc. (NYSE: PFE) had its price target lowered by analysts at Guggenheim from $35.00 to $33.00. They now have a "buy" rating on the stock.
Ratings data for PFE provided by MarketBeat
In the thread Trading Pfizer Inc.
Die von Guggenheim gewählte maximale Laufzeit wurde überschritten